Posts by Joel S. Finkelstein, MD
-
Ivacaftor Improves Skeletal Outcomes in Patients with Cystic Fibrosis
In the first prospective study of its kind, a team led by Massachusetts General Hopsital found evidence that ivacaftor improves bone density and microarchitecture in children and adults with cystic fibrosis who have the G551D-CFTR mutation.
Digestive Healthcare at Mass General
The Massachusetts General Hospital Digestive Healthcare Center is a collaborative practice of gastroenterologists, endoscopists, surgeons, radiologists, pathologists, hepatologists, oncologists and radiation oncologists dedicated to the prevention, diagnosis, treatment and management of digestive diseases.